Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Stem Cell Culture01:17

Stem Cell Culture

Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...
Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
iPS Cell Differentiation01:22

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
Mesenchymal Stem Cells01:19

Mesenchymal Stem Cells

Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their access...
Embryonic Stem Cells00:58

Embryonic Stem Cells

Embryonic stem (ES) cells are undifferentiated pluripotent cells, meaning they can produce any cell type in the body. This gives them tremendous potential in science and medicine since they can generate specific cell types for use in research or to replace body cells lost due to damage or disease.
Embryonic Stem Cells00:57

Embryonic Stem Cells

Embryonic stem (ES) cells were first discovered in mice in 1981 by Martin Evans. In 1998, James Thomson identified a method to isolate embryonic stem cells from humans. Human embryonic stem cells (hESCs) are obtained from 3-5 day old embryos that remain unused after an in vitro fertilization procedure.
ES cells are grown in a culture medium where they can divide indefinitely, creating ES cell lines. Under certain conditions, ES cells can differentiate, either spontaneously into a variety of...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Glial-restricted precursors: patterns of expression of opioid receptors and relationship to human immunodeficiency virus-1 Tat and morphine susceptibility in vitro.

Neuroscience·2007
Same author

The story so far in R&D.

Drug news & perspectives·2007
Same author

Highlights from the Fifth International Meeting on Metabotropic Glutamate Receptors, held September 18-23, 2005, in Taormina, Sicily, Italy. Metabotropic glutamate receptors as therapeutic targets.

Drug news & perspectives·2006
Same author

Chronicles in drug discovery.

Drug news & perspectives·2006
Same journal

2nd international conference on hypertension, lipids, diabetes and stroke prevention.

Timely topics in medicine. Cardiovascular diseases·2008
Same journal

Current challenges and directions in antithrombotic therapy.

Timely topics in medicine. Cardiovascular diseases·2008
Same journal

Myocardial infarction.

Timely topics in medicine. Cardiovascular diseases·2008
Same journal

Web-based medical symposia.

Timely topics in medicine. Cardiovascular diseases·2008
Same journal

The early effects of elevated glucose on endothelial function as a target in the treatment of type 2 diabetes.

Timely topics in medicine. Cardiovascular diseases·2008
Same journal

Coronary disease.

Timely topics in medicine. Cardiovascular diseases·2008
See all related articles

Related Experiment Video

Updated: Jul 7, 2026

High Throughput Characterization of Adult Stem Cells Engineered for Delivery of Therapeutic Factors for Neuroprotective Strategies
09:19

High Throughput Characterization of Adult Stem Cells Engineered for Delivery of Therapeutic Factors for Neuroprotective Strategies

Published on: January 4, 2015

Stem cells: therapeutic present and future.

V K Khurdayan

    Timely Topics in Medicine. Cardiovascular Diseases
    |February 26, 2008
    PubMed
    Summary
    This summary is machine-generated.

    Stem cells, unspecialized cells with therapeutic potential, are being investigated for degenerative diseases and drug discovery. Their ability to renew and differentiate offers promise for treating conditions like heart failure and cancer.

    More Related Videos

    Evaluation of Stem Cell Therapies in a Bilateral Patellar Tendon Injury Model in Rats
    09:31

    Evaluation of Stem Cell Therapies in a Bilateral Patellar Tendon Injury Model in Rats

    Published on: March 30, 2018

    Pluripotent Stem Cell Derived Cardiac Cells for Myocardial Repair
    06:37

    Pluripotent Stem Cell Derived Cardiac Cells for Myocardial Repair

    Published on: February 3, 2017

    Related Experiment Videos

    Last Updated: Jul 7, 2026

    High Throughput Characterization of Adult Stem Cells Engineered for Delivery of Therapeutic Factors for Neuroprotective Strategies
    09:19

    High Throughput Characterization of Adult Stem Cells Engineered for Delivery of Therapeutic Factors for Neuroprotective Strategies

    Published on: January 4, 2015

    Evaluation of Stem Cell Therapies in a Bilateral Patellar Tendon Injury Model in Rats
    09:31

    Evaluation of Stem Cell Therapies in a Bilateral Patellar Tendon Injury Model in Rats

    Published on: March 30, 2018

    Pluripotent Stem Cell Derived Cardiac Cells for Myocardial Repair
    06:37

    Pluripotent Stem Cell Derived Cardiac Cells for Myocardial Repair

    Published on: February 3, 2017

    Area of Science:

    • Regenerative Medicine
    • Biotechnology

    Background:

    • Embryonic stem cells, isolated in the 1990s, are unspecialized cells with self-renewal and differentiation capabilities.
    • Stem cells offer significant therapeutic promise for degenerative diseases.

    Purpose of the Study:

    • To explore the therapeutic applications of stem cells in various degenerative diseases.
    • To highlight the role of stem cells in drug discovery and preclinical testing.

    Main Methods:

    • Active investigation in preclinical and clinical settings.
    • Utilizing stem cells as tools for drug discovery and clinical models.

    Main Results:

    • Stem cells are being investigated for heart failure, ALS, spinal cord injury, stroke, and more.
    • The biotech and pharmaceutical industries recognize stem cells for drug discovery and preclinical testing.

    Conclusions:

    • Stem cell research continues to advance, holding promise for treating a wide range of diseases.
    • Stem cells are valuable tools in pharmaceutical development, aiding in the transition of compounds to clinical trials.